Company / R&D Expense
UFP Technologies, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$8.6M
FY2025
5-year range
$7.2M / $10.4M
FY2021-FY2025
Trend
-17.3%
vs FY2024
Sector context
#101 of 105
Health Care
What the data says
Among 105 Health Care companies, UFP Technologies, Inc. is in the bottom 4% for r&d expense. R&D Expense has fluctuated over the past 10 years, ranging from $1M in FY2016 to $11M in FY2018.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +1.0%.
Improved from $7M to $9M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 105This company $8.6M Sector average $284.2M
▼
-97.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.0%, indicating consistent growth.
- In FY2025, r&d expense decreased 17.3% year-over-year.
- Ranks #101 out of 105 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Strong profit margin: 39.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.6M | -17.3% |
| FY2024 | $10.4M | +44.4% |
| FY2023 | $7.2M | -22.6% |
| FY2022 | $9.3M | +9.4% |
| FY2021 | $8.5M | +3.7% |
| FY2020 | $8.2M | -6.8% |
| FY2019 | $8.8M | -16.2% |
| FY2018 | $10.5M | +110.0% |
| FY2017 | $5.0M | +284.6% |
| FY2016 | $1.3M | +0.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026